Related Experiment Video
Updated: Aug 5, 2025

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
Applications of Artificial Intelligence in Thrombocytopenia
Amgad M Elshoeibi1, Khaled Ferih1, Ahmed Adel Elsabagh1
1College of Medicine, QU Health, Qatar University, Doha 2713, Qatar.
Artificial intelligence shows promise in diagnosing and predicting outcomes for thrombocytopenia, a condition of low platelet counts. Machine learning algorithms can enhance early detection and clinical management of this potentially dangerous bleeding disorder.
Area of Science:
- Medical Informatics
- Hematology
- Artificial Intelligence
Background:
- Thrombocytopenia, characterized by a critically low platelet count, poses significant health risks due to potential excessive bleeding.
- Early detection and evaluation are crucial for timely intervention and improved patient outcomes in thrombocytopenia.
- Various factors, including medications, sepsis, viral infections, and autoimmunity, can cause thrombocytopenia.
Purpose of the Study:
- To review the application of machine learning algorithms in the diagnosis, prognosis, and patient distribution of thrombocytopenia.
- To summarize the methodologies and findings of studies utilizing artificial intelligence for thrombocytopenia management.
- To assess the potential of artificial intelligence in enhancing clinical approaches for thrombocytopenia.
Main Methods:
- A systematic literature search was conducted across four databases.
- 13 original articles focusing on machine learning applications for thrombocytopenia were identified and reviewed.
- Methods and findings from included studies were summarized.
Main Results:
- Studies demonstrated that artificial intelligence can effectively analyze complex variables for diagnosing thrombocytopenia.
- Machine learning models showed potential in assessing patient prognosis and predicting disease distribution.
- The review highlighted the capability of AI to enhance early detection and evaluation of thrombocytopenia.
Conclusions:
- Artificial intelligence holds significant potential to improve the clinical diagnosis of thrombocytopenia.
- AI-driven tools can aid in predicting prognosis and guiding treatment strategies for patients with low platelet counts.
- The integration of machine learning can enhance the overall management and patient outcomes in thrombocytopenia.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

